"Hahne Regional Cancer Center provides comprehensive cancer care for patients in a modern facility. Beyond providing physical treatment through chemotherapy and radiation therapy, we focus on meeting the personal and emotional needs of the patient as well. Our goal is to ease stress by helping patients and their families deal with medical insurance, finances, home healthcare, transportation and any other issues that are troublesome. Many support services are available and can be arranged through the center. In addition to caring for people with a cancer diagnosis, patients with non-cancerous diseases, usually of the blood, are often referred to the center for evaluation and treatment."

During the past decade, Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" #1 sponsor was "NSABP Foundation Inc" with 4 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" are "Breast Cancer" (4 trials), "Lung Cancer" (3 trials), "Colorectal Cancer" (1 trials), "Esophageal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" are "Drug" (9 trials), "Biological" (3 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "anastrozole" (2 trials), "cisplatin" (2 trials), "fluorouracil" (2 trials), "radiation therapy" (2 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".